3 Things to Watch on the TSX Index on Thursday

The U.S. stock futures were extremely volatile Thursday before the markets opened. However, China’s comments about working with the U.S. on trade could deliver gains rebounding from a disastrous Wednesday.  

The U.S. stock futures were extremely volatile Thursday before the markets opened. 

However, China’s comments about working with the U.S. on trade could deliver gains Thursday, rebounding nicely from a disastrous Wednesday.  

Here’s what to watch on the TSX on Thursday. 

Canopy Growth delivers anything but…

Canopy Growth (TSX:WEED)(NYSE:CGC) stock dropped by 14% in pre-market trading Thursday after Canada’s largest cannabis company delivered a stinker of an earnings report Wednesday. Analysts were anything but complimentary about its slowing growth. 

The company was expected to generate $107.1 million in revenue in Q1 2020. It was only able to produce $90.5 million in sales in the quarter. On the bottom line, analysts expected it to lose $0.70 in the quarter; it actually lost $1.28 a share, 83% worse than the consensus. 

There were two positives from the quarter. 

First, revenues were up 249% from the $25.9 million last year. Second, Canopy harvested more than 40,000 kilograms of cannabis in the second quarter, a company record, 183% higher than in the fourth quarter. 

It will be interesting to see how Canopy’s stock trades on Thursday now that investors have had a chance to digest the numbers. 

Bombardier looks attractive

Bombardier (TSX:BBD.B) traded four cents lower on Wednesday, closing the day’s trading at $1.71, just 12 cents off its 52-week low. 

Citi analyst Stephen Trent characterized Bombardier’s stock as “fairly battered” but believes its long-term prognosis is good. 

“Is Bombardier done with asset sales? Only management could answer that question with certainty.

That said, Bombardier now seems well focused on its business jet and transport segments,” Trent wrote in a note to clients Wednesday. “Our forecast does not assume any asset sales, beyond what has already been announced, such as the Q400 and CRJ commercial aircraft programs.”

Trent’s target price for Bombardier is $2,75, below the average analyst price of $3.36, but still providing 61% upside based on current prices. 

Canada Goose looks ready to fly 

Talk about stocks that have taken it on the chin in 2019. 

Canada Goose (TSX:GOOS)(NYSE:GOOS) reported Q1 2020 results Wednesday. Investors weren’t happy with its results or outlook sending its stock down by more than 7.5%. 

However, if investors take a closer look at Canada Goose’s results, D.A. Davidson analyst John Morris believes the company is one of the best names out there, doing everything it can to continue growing. 

“We continue to view GOOS as well-positioned given the company’s growth initiatives, global expansion opportunities, and continued investments in IT and infrastructure to support flexibility and scalability opportunities,” Morris said in a note to clients. 

The analyst has a “buy” rating on Canada Goose with a US$48 target price.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Will Ashworth has no position in any stocks mentioned.  

More on Cannabis Stocks

Stethoscope with dollar shaped cord
Cannabis Stocks

Best Stock to Buy Right Now: Bausch Health vs Canopy Growth?

While both stocks are risky, Bausch Health is seeing operational momentum, while Canopy Growth is still struggling with losses.

Read more »

Worker checks cannabis flower in lab farm greenhouse
Cannabis Stocks

Down an Incredible 99% From All-Time Highs, Is Canopy Growth Stock Worth Buying Now?

Canopy Growth stock remains a high-risk investment in 2025 due to its weak balance sheet and volatile profit margins.

Read more »

money goes up and down in balance
Dividend Stocks

2 Incredibly Cheap Growth Stocks to Buy Now

These two growth stocks are both unbelievably cheap and have significant long-term potential, making them some of the best to…

Read more »

A cannabis plant grows.
Stocks for Beginners

1 Canadian Cannabis Stock Down 57% to Buy Now for Future Growth

Cannabis stocks might seem so 2018, but this one could eventually make a major comeback.

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Stocks for Beginners

Buy the Dip Before It’s Too Late: This Canadian Stock Won’t Stay Cheap Forever

Investors might think that cannabis stocks are out, but this one could be the top Canadian stock to consider.

Read more »

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »